Tuesday, June 2, 2020

COVID-19 drug | No approval yet for Indian companies to market remdesivir: Report

COVID-19 drug | No approval yet for Indian companies to market remdesivir: Report It is the only drug so far that has shown significant effect on patients infected with COVID-19.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-drug-|-no-approval-yet-for-indian-companies-to-market-remdesivir-report_13853361.html
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bulls return to D-Street as falling oil prices ease geopolitical jitters

Indian stock markets experienced a significant rally on Wednesday. Both the Nifty 50 and S&P BSE Sensex saw gains exceeding 1 percent. T...